2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for Pts With Unresectable or Metastatic SSTR+ GEP-NETs"

199 views
June 6, 2024

Chapters

Introduction & Therapy Overview

00:00

Clinical Trial Results & Safety

01:09

0 Comments
Login to view comments. Click here to Login